cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
Published 8 years ago • 474 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
4:12
cabosun trial of cabozantinib - could it change how we treat frontline rcc?
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
6:30
cabozantinib: the meteor trial
-
5:49
cabozantinib improves advanced kidney cancer survival: meteor trial results
-
6:26
esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
-
0:57
fda approves cabozantinib for advanced rcc
-
1:05
cohort 1 litespark-003: belzutifan cabozantinib 1l treatment for advanced rcc
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
0:50
cassiope: cabozantinib in the real-word for rcc
-
3:43
telaglenastat plus cabozantinib for advanced renal cell carcinoma
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc
-
2:28
the role of cabozantinib in renal cell carcinoma
-
3:16
cabosun: upfront use of cabozantinib for mrcc
-
3:53
cabozantinib in combination with immunotherapy for advanced renal cell carcinoma
-
1:25
managing side effects of cabozantinib treatment for metastatic renal cell carcinoma
-
3:04
fda approves nivolumab plus cabozantinib for advanced renal cell carcinoma